Brain Canada is pleased to be partnering with Alzheimer’s Association (ALZ) to jointly launch the Advancing Research on Care and Outcome Measurement (ARCOM) funding program, an international and collaborative competition aimed at addressing the significant measurement gaps in care and outcomes across diverse and underrepresented populations and stages of dementia.
This program will provide an exceptional opportunity for Canadian researchers to join the international research community and contribute to an underfunded area of focus to help ensure care providers are implementing evidence-based practices and achieving desired outcomes. Through this partnership, Brain Canada is committing up to the equivalent of $750,000 CAD to Canadian-led teams who meet peer review recommendations.
Increasing equity, diversity and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities.
Click here to view the Request for Applications.
Deadline for receipt of Letters of Intent: May 5, 2021 at 17:00 ET
Deadline for receipt of Full Applications: June 29, 2021 at 17:00 ET